Richard Bagley

Presidente presso Samus Therapeutics, Inc.

80 anni

Health Technology

Energy Minerals

Consumer Services

Posizioni attive di Richard Bagley

Società	Posizione	Inizio	Fine
Samus Therapeutics, Inc. Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA.	Presidente	01/11/2016	-

Società	Posizione	Inizio	Fine
ALAUNOS THERAPEUTICS, INC.	Direttore/Membro del Consiglio	23/06/2011	16/07/2012
	Direttore operativo	01/09/2005	16/07/2012
	Direttore Finanziario/CFO	01/09/2005	09/05/2012
	Presidente	01/09/2005	16/07/2012
	Treasurer	01/09/2005	09/07/2012
ZIOPHARM, Inc.	Direttore operativo	01/07/2004	01/09/2005
ZIOPHARM, Inc.	Presidente	01/07/2004	01/09/2005
TWIN BUTTE ENERGY LTD.	Presidente	01/01/1998	01/05/2003
ProScript, Inc. ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million.	Presidente	01/01/1994	01/01/1998
	Presidente	01/01/1994	01/01/1998
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN.	Presidente	01/01/1990	01/01/1994
E. R. Squibb & Sons LLC	Presidente	01/01/1988	01/01/1989
Smithkline & French Laboratories US, Inc.	Corporate Officer/Principal	01/01/1968	01/01/1985

Harvard Graduate School of Education

Graduate Degree

Distribuzione geografica

Stati Uniti	9
Canada	2

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
TWIN BUTTE ENERGY LTD.	Energy Minerals
ALAUNOS THERAPEUTICS, INC.	Health Technology

Aziende private	6
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN.	Health Technology
ZIOPHARM, Inc.	Health Technology
ProScript, Inc. ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million.	Health Technology
Smithkline & French Laboratories US, Inc.
E. R. Squibb & Sons LLC
Samus Therapeutics, Inc. Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA.	Health Technology